Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-25

Clinical Trial Update: A Phase II Single-Arm Study of High-Bioavailability Curcumin as Neoadjuvant Chemoradiotherapy in Mid-to-Low Rectal Cancer: Integrated Clinical and Translational Analysis of Tumor Tissue [Phase 2]

View source ↗

Summary

A Phase II single-arm study examines high-bioavailability curcumin as part of neoadjuvant chemoradiotherapy for rectal cancer, with integrated clinical and tran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • High-Bioavailability Curcumin (curcumin (high-bioavailability formulation))

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Rectal Cancer, Locally Advanced Rectal Cancer | Phase 2 | Status: NOT_YET_RECRUITING